Top shareholders of INAB - IN8BIO, INC. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.
Institutional Holders of IN8BIO, INC. - Common Stock, par value $0.0001 per share (INAB) as of Q3 2021
As of 30 Sep 2021,
IN8BIO, INC. - Common Stock, par value $0.0001 per share (INAB) was held by
11 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,772,756 shares.
The largest 10 holders included
Capital World Investors, Nantahala Capital Management, LLC, B. Riley Financial, Inc., VANGUARD GROUP INC, Voss Capital, LLC, Tudor Investment Corp Et Al, Rock Creek Group, LP, MILLENNIUM MANAGEMENT LLC, BlackRock Inc., and UBS Group AG.
This page lists
11
institutional shareholders reporting positions in this security
for the Q3 2021 filing period.
Investor
Option
Weight %
Change %
Value $
* Price
Shares
Share Change
Activity
Report Period
Compare Q3 2021 vs Q3 2025 Across Filers
Q3 2025 holders
1
Q3 2021 holders
11
Holder diff
10
Investor
Q3 2025 Shares
Q3 2021 Shares
Share Diff
Share Chg %
Q3 2025 Value $
Q3 2021 Value $
Value Diff $
Value Chg %
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance
the user experience and, if you allow them, measure engagement and deliver
advertising. Analytics and marketing storage stay off until you grant
consent. By clicking on "Agree and continue", you declare your consent to
the use of the selected optional cookies.
Here
you can make detailed settings or revoke your consent (in part if necessary)
with effect for the future. For further information, please refer to our
Privacy Policy
.